What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Sona Nanotech Inc.

Name: Sona Nanotech Inc.
Address: 1 Research Drive, Dartmouth, NS, B2Y4M9, CA
Telephone: +19028809925

Home
Canada
Dartmouth, NS
Sona Nanotech Inc.

Our unique CTAB-free gold nanorods are powering the next generation of lateral flow diagnostic tests

03/25/2024

Sona Nanotech Inc. announces positive interim results from its study with The Giacomantonio Immuno-Oncology Research Group at Dalhousie University. An update received by the Company indicates that all tumors treated within the Study to date with a single Targeted Hyperthermia Therapy (“THT”) treatment shrunk within the first 24 hours, with an average reduction in size of 80% compared to matched controls.

Read the full press release here: https://bit.ly/3ITVajU

03/18/2024

Sona Nanotech Inc. announces that it has submitted a provisional patent application with the United States Patent and Trademark Office, for its proprietary photothermal light device, entitled, “ENDOSCOPE WITH EMR OPTICAL FIBER AND THERMAL SENSOR FOR PHOTOTHERMAL THERAPY”.

Read the full press release here: https://bit.ly/4agSW9J

02/07/2024

This clip from Sona Nanotech's latest webinar highlights the key advancements in targeted hypothermia therapy.
Learn about their strategic partnerships, IP protection, and insights from Sona team.

Watch the full webinar extract here: https://youtu.be/wzUCtMsd2G0

02/01/2024

Dr. Carman Giacomantonio, Principal Investigator for Sona Nanotech's current cancer treatment efficacy study at Dalhousie Medical School, shares insights on the potential for gold nanoparticles in cancer treatment.

Watch the video to learn how Sona's approach could enhance immune responses and transform cancer therapies: https://youtu.be/uJ5nFsas0Pk

01/29/2024

Watch the replay of Sona Nanotech's insightful webinar hosted by CEO David Regan, CSO Len Pagliaro, and Dr. Carman Giacomantonio.

Gain valuable insight into Sona's Targeted Hyperthermia Therapy and its potential in cancer treatment. Don't miss this opportunity to learn about Sona's technology and ongoing research study.

Watch the replay now to stay informed: https://youtu.be/EjyGim8Pqqw

01/25/2024

Sona Nanotech's CEO David Regan and CSO Len Pagliaro will be presenting their first update of 2024 today. They will be joined by Dr. Carman Giacomantonio, the principal investigator for the company’s ongoing research study into the efficacy and safety of Sona's pre-clinical Targeted Hyperthermia Therapy (“THT”), which leverages Sona's uniquely biocompatible Gold Nanorods with a view to treating certain cancers.

This is a great opportunity to learn more about Sona's proprietary technology and its innovative study which will assess THT’s ability to act as a catalyst to generate immune responses.

The session will end with a Q&A, register today: https://bit.ly/3O9DDqL

01/24/2024

Sona Nanotech's CEO David Regan and CSO Len Pagliaro will be presenting their first update of 2024 tomorrow. They will be joined by Dr. Carman Giacomantonio, the principal investigator for the company’s ongoing research study into the efficacy and safety of Sona's pre-clinical Targeted Hyperthermia Therapy (“THT”), which leverages Sona's uniquely biocompatible Gold Nanorods with a view to treating certain cancers.

This is a great opportunity to learn more about Sona's proprietary technology and its innovative study which will assess THT’s ability to act as a catalyst to generate immune responses.

The session will end with a Q&A, register today: https://bit.ly/3O9DDqL

01/18/2024

Sona Nanotech's CEO David Regan and CSO Len Pagliaro will be presenting their first update of 2024 on January 25th. They will be joined by Dr. Carman Giacomantonio, the principal investigator for the company’s ongoing research study into the efficacy and safety of Sona's pre-clinical Targeted Hyperthermia Therapy (“THT”), which leverages Sona's uniquely biocompatible Gold Nanorods with a view to treating certain cancers.

This is a great opportunity to learn more about Sona's proprietary technology and its innovative study which will assess THT’s ability to act as a catalyst to generate immune responses.

The session will end with a Q&A, register today: https://bit.ly/3O9DDqL

12/22/2023

Sona Nanotech extends warm wishes and a prosperous New Year to all our stakeholders. We look forward to progressing our journey in advancing medical technologies in 2024.

11/27/2023

Sona Nanotech Inc. is pleased to announce that it has closed its private placement that was announced on October 18, 2023 with the issuance of 3,750,000 shares at $0.20 per share and 1,875,000 common share purchase warrants exercisable to purchase an additional common share of Sona at a price of $0.30 per share until November 24, 2025.

Read the press release here: https://bit.ly/46yQtVO

11/23/2023

In Sona Nanotech's recent webinar, the journey ahead is explained. Here is a preview of what is to come:

- Panel of experts providing invaluable guidance.
- Selection of pre-clinical study partners and research collaborations.
- Partner selection for GMP gold nanorod manufacturing.
- Securing first in-human studies once comprehensive safety and biocompatibility data is obtained.

Listen to the extract to hear more on Sona’s plans: https://youtu.be/wVI5vKE7DJU

Address

1 Research Drive
Dartmouth, NS
B2Y4M9

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+19028809925

Website

https://sonanano.com/

Alerts

Be the first to know and let us send you an email when Sona Nanotech Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Sona Nanotech Inc.:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Business
Claim ownership or report listing

Want your business to be the top-listed Engineering Company in Dartmouth?